Sanofi stock: EUR 83.81, down 0.89% before Xetra open
Published on 11/06/2026 at 08:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSanofi enters a busy November
- Sanofi reported double-digit sales and business EPS growth for the third quarter of 2026.
- The company upgraded its full-year 2026 guidance after the third-quarter update.
- Sanofi is scheduled to attend the Wolfe Research Healthcare Conference in New York on November 10, 2026.
The real-time quote of Sanofi stock showed Sanofi stock trading at EUR 83.81 on Lang & Schwarz at 08:33 CET on Friday, November 6, 2026, down 0.89 percent from the Xetra close of Thursday, November 5, at EUR 84.56.
Sanofi's investor relations page lists the third-quarter 2026 results as reviewed with the financial community on October 30. The accompanying release highlighted double-digit growth in sales and business EPS and an upgraded full-year 2026 guidance. The update gives investors a fresh reference point as the company moves toward its next scheduled conference appearance.
Sanofi's investor relations page also lists the Wolfe Research Healthcare Conference in New York for November 10, 2026. The event is followed by the Jefferies Global Healthcare Conference in London on November 17, where Vaccines executive vice president Thomas Triomphe is scheduled to speak. These dates keep management access and guidance commentary in focus for healthcare investors.
The company published these details on its Sanofi Investor Relations page.
The CAC 40 provides the relevant French equity-market backdrop for Sanofi investors.
